Skip to Main Content

Paper Details

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
Cancer Cell
164
2018
ESRP1, Prostate Cancer, patient, patients, prostate cancer, prostate cancers, tissue, tumor, tumors
Adult, Biomarkers, Tumor, DNA Methylation, Evolution, Molecular, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Mutation, Prostatic Neoplasms, RNA-Binding Proteins, Risk Factors, Transcriptome, Whole Genome Sequencing
Author NameAffiliation
Clarissa Gerh??userGerman Cancer Research Center (DKFZ)
Francesco FaveroRigshospitalet, University of Copenhagen
Thomas RischMax Planck Institute for Molecular Genetics
Ronald SimonUniversity Medical Center Hamburg-Eppendorf
Lars FeuerbachGerman Cancer Research Center (DKFZ)
Yassen AssenovGerman Cancer Research Center (DKFZ)
Doreen HeckmannGerman Cancer Research Center (DKFZ)
Nikos SidiropoulosRigshospitalet, University of Copenhagen
Sebastian M Waszak
Sebastian M Waszak
Daniel H??bschmannGerman Cancer Research Center (DKFZ), Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, University Hospital
Daniel H??bschmannGerman Cancer Research Center (DKFZ), Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, University Hospital
Alfonso UrbanucciUniversity of Oslo, Norway Institute for Cancer Genetics and Informatics, Oslo University Hospital, Institute for Cancer Research
Etsehiwot G GirmaRigshospitalet, University of Copenhagen
Vladimir KuryshevGerman Cancer Research Center (DKFZ)
Leszek J KlimczakNational Institute of Environmental Health Sciences
Natalie SainiNational Institute of Environmental Health Sciences
Adrian M St??tz
Dieter WeichenhanGerman Cancer Research Center (DKFZ)
Lisa-Marie B??ttcherUniversity Medical Center Hamburg-Eppendorf
Reka TothGerman Cancer Research Center (DKFZ)
Josephine D HendriksenRigshospitalet, University of Copenhagen
Christina M??ller-KoopUniversity Medical Center Hamburg-Eppendorf
Pavlo LutsikGerman Cancer Research Center (DKFZ)
S??ren MatzkMax Planck Institute for Molecular Genetics
Hans-J??rg WarnatzMax Planck Institute for Molecular Genetics
Vyacheslav AmstislavskiyMax Planck Institute for Molecular Genetics
Clarissa FeuersteinGerman Cancer Research Center (DKFZ), Heidelberg University
Benjamin Raeder
Olga BogatyrovaGerman Cancer Research Center (DKFZ)
Eva-Maria Schmitz
Claudia Hube-MaggUniversity Medical Center Hamburg-Eppendorf
Martina KluthUniversity Medical Center Hamburg-Eppendorf
Hartwig HulandMartini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf
Markus GraefenMartini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf
Chris LawerenzGerman Cancer Research Center (DKFZ)
Chris LawerenzGerman Cancer Research Center (DKFZ)
Gervaise H HenryUT Southwestern Medical Center
Takafumi N YamaguchiOntario Institute for Cancer Research
Alicia MalewskaUT Southwestern Medical Center
Jan MeinersUniversity Medical Center Hamburg-Eppendorf
Daniela SchillingGerman Cancer Research Center (DKFZ), National Center for Tumor Diseases and German Cancer Research Center
Eva ReisingerGerman Cancer Research Center (DKFZ)
Roland EilsGerman Cancer Research Center (DKFZ), Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg
Roland EilsGerman Cancer Research Center (DKFZ), Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg
Matthias SchlesnerGerman Cancer Research Center (DKFZ)
Matthias SchlesnerGerman Cancer Research Center (DKFZ)
Douglas W StrandUT Southwestern Medical Center
Robert G BristowManchester Cancer Research Centre, University of Manchester
Paul C BoutrosOntario Institute for Cancer Research, University of Toronto
  • 1 - 50

Datasets